Spinal skin stimulation plus augmented reality training for pain and balance in diabetic neuropathy
Tests combined spinal stimulation and augmented reality training for pain and balance in diabetic neuropathy.
Key facts
- Who runs it
- Riphah International University
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- tSCS and AR on Pain and Balance in Diabetic Peripheral Neuropathy
- Status
- Not yet recruiting
- People taking part
- 36 people, planned
- Started
- 15 Jun 2026
- Expected to end
- 31 Jan 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- transcutaneous spinal cord stimulation
- Augmented Reality
- Record updated
- 2 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with nerve pain from diabetic neuropathy (nerve damage caused by diabetes). It tests skin-surface spinal cord stimulation, augmented reality training, or both, for pain and balance.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Diabetic neuropathy with a score of 4 or more on the Douleur Neuropathique 4 Questionnaire, and pain of 4 or more on the Numeric Pain Rating Scale (NPRS).
- Biomarker or test result
- Vibration sense test: 6 Hz or more on a Neurothesiometer.
Main reasons for not taking part
- Problems with memory or thinking (MOCA ≤ 26/30)
- Metal implants in the skull
- Having a shunt
- Skin allergy
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- More than or equals to 4 score on Douleur Neuropathique 4 Questionnaire
- More than or equals to 6 Hz at Neurothesiometer
- More than or equals to 4 score on the Numeric Pain Rating Scale (NPRS)
Who cannot take part
- Metallic implants at skull
- Skin allergy
- Cognitively compromised (MOCA ≤ 26/30)
- Shunting
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
tSCS and AR-based training have individually shown benefits in neuromotor rehabilitation; no study to date has evaluated their combined effects on pain, balance, lower-limb strength, retention, and vibration sense in diabetic neuropathy. The rationale for combining them lies in their complementary mechanisms: tSCS at 30 Hz activates large-diameter Aβ afferents, inhibiting nociceptive input, enhancing spinal excitability, and facilitating motor activation.
The 3 groups in the trial
- Transcutaneous spinal cord stimulation and Augmented Reality GroupTreatment being tested
Treatment: transcutaneous spinal cord stimulation and Augmented Reality
- Augmented Reality GroupExisting treatment, for comparison
Treatment: Augmented Reality
- Transcutaneous spinal cord stimulation GroupExisting treatment, for comparison
Treatment: transcutaneous spinal cord stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Combined Effects of Transcutaneous Spinal Cord Stimulation (tSCS) and Augmented Reality (AR) Training on Pain and Balance in Diabetic Neuropathy Patients.
- Plain-language title
- Spinal skin stimulation plus augmented reality training for pain and balance in diabetic neuropathyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 2 June 2026